Fig. 5From: Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaGlobal treatment landscape of patients rendered NED or NPRD. The date of local therapy is represented as year zero. Patients rendered NPRD are denoted with an asterisk (*). The top 25 patients had progression in established tumors while the bottom 27 had progression with new tumorsBack to article page